News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,005 Results
Type
Article (39302)
Company Profile (247)
Press Release (651456)
Section
Business (203981)
Career Advice (2002)
Deals (35398)
Drug Delivery (89)
Drug Development (80916)
Employer Resources (169)
FDA (16122)
Job Trends (14820)
News (344799)
Policy (32467)
Tag
Academia (2530)
Alliances (49290)
Alzheimer's disease (1300)
Approvals (16091)
Artificial intelligence (183)
Bankruptcy (354)
Best Places to Work (11624)
Biotechnology (175)
Breast cancer (216)
Cancer (1602)
Cardiovascular disease (122)
Career advice (1667)
Cell therapy (323)
Clinical research (65074)
Collaboration (611)
Compensation (321)
COVID-19 (2556)
C-suite (142)
Data (1513)
Diabetes (197)
Diagnostics (6238)
Earnings (85148)
Employer resources (146)
Events (110568)
Executive appointments (528)
FDA (16948)
Funding (558)
Gene therapy (224)
GLP-1 (636)
Government (4351)
Healthcare (18743)
Infectious disease (2657)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16428)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7878)
Lung cancer (238)
Manufacturing (222)
Medical device (13246)
Medtech (13251)
Mergers & acquisitions (19288)
Metabolic disorders (518)
Neuroscience (1684)
NextGen: Class of 2025 (6508)
Non-profit (4474)
Northern California (1939)
Obesity (294)
Opinion (189)
Parkinson's disease (113)
Patents (138)
People (56732)
Phase I (20262)
Phase II (28662)
Phase III (21346)
Pipeline (645)
Postmarket research (2562)
Preclinical (8562)
Radiopharmaceuticals (240)
Rare diseases (303)
Real estate (5894)
Regulatory (21839)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1674)
Startups (3567)
United States (17373)
Vaccines (594)
Weight loss (201)
Date
Today (131)
Last 7 days (597)
Last 30 days (2805)
Last 365 days (34726)
2025 (2894)
2024 (35217)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46542)
2018 (35020)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (714)
Arizona (206)
Asia (37441)
Australia (6119)
California (4439)
Canada (1620)
China (371)
Colorado (202)
Connecticut (211)
Europe (80213)
Florida (643)
Georgia (155)
Illinois (439)
Indiana (249)
Maryland (703)
Massachusetts (3420)
Michigan (190)
Minnesota (325)
New Jersey (1259)
New York (1277)
North Carolina (803)
Northern California (1939)
Ohio (164)
Pennsylvania (1037)
South America (1093)
Southern California (1674)
Texas (647)
Utah (131)
Washington State (440)
691,005 Results for "nextcure inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NextCure Announces Acceptance of IND Application for LNCB74
December 11, 2024
·
3 min read
Press Releases
NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference
November 27, 2024
·
2 min read
BioCapital
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies, today announced that it will present and host institutional investor meetings at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 20, 2024
·
2 min read
Press Releases
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
January 10, 2025
·
3 min read
BioCapital
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
NextCure, Inc. announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11th, at 12:45 pm ET.
April 2, 2024
·
2 min read
Drug Development
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
NextCure, Inc. today announced that clinical data from the Phase 1b portion of a Phase 1b/2 study evaluating NC410, a LAIR-2 fusion protein, in combination with pembrolizumab will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
May 30, 2024
·
5 min read
Press Releases
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
November 8, 2024
·
7 min read
Business
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, announced the appointment of Rakesh Dixit, PhD, to its Scientific Advisory Board.
April 4, 2024
·
3 min read
Business
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer, today provided a business update and reported its first-quarter 2024 financial results.
May 2, 2024
·
6 min read
News
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
October 4, 2024
·
2 min read
1 of 69,101
Next
